Arakhamia: Bill 8371 will be finalized on the international front and voted on
The head of the ‘Servant of the People’ faction, David Arakhamia. Photo: RBC-Ukraine
The head of the ‘Servant of the People’ faction, David Arakhamia, announced the finalization and voting of the law 8371, which is aimed at the actual ban on the activities of the UOC, reports the Left Bank.
"We have an agreement with all factions on how to proceed and reach a vote in the next session (starting from August 21). It is very likely that the law will be slightly revised, but with consensus. I hope that the State Service for Ethnopolitics and Freedom of Conscience (DESS) will also agree. A preliminary plan: until 15.08 – behind-the-scenes work on the international front. 15-20.08 – finalization in the committee. 21-22.08 – voting in the hall," Arakhamia wrote in the party chat.
As reported by UOJ, the European Solidarity through local councillors is trying to put pressure on MPs to put the bill on banning the Church to a vote.
Read also
UOC Primate blesses special prayer rule for Great Lent
Metropolitan Onuphry blessed to pray for peace in Ukraine during Great Lent.
In Britain, Christians are no longer the majority
According to a Pew Research Center study, the share of Christians in the United Kingdom has fallen below 50%.
His Beatitude Onuphry addresses flock before Great Lent
The Primate of the UOC blessed the faithful for the upcoming Great Lent.
Lavra Reserve complains to UNESCO about heating and power outage
International experts studied possible threats to the Kyiv-Pechersk Lavra – from missile strikes to power and heating outages.
Konotop Eparchy Administration is under repair after shelling
The replacement of the windows damaged as a result of the shelling in the Church of All Saints and the building of the Konotop Eparchy has become possible thanks to donations from believers.
Priests and laity of Rivne Eparchy donate blood for children with cancer
In Rivne, the UOC clergy and laity have donated blood for children undergoing treatment for cancer.